From atopic dermatitis to contact dermatitis, discover expert-backed treatments and lifestyle changes that can help manage ...

Biologic treatments are a new option for people with moderate to severe eczema or atopic dermatitis. Most people can control eczema with prevention techniques, topical treatments, or ultraviolet ...

SAN CARLOS, CA and FORT WORTH, TX / ACCESSWIRE / January 9, 2025 / CAGE Bio, Inc., a clinical-stage biotechnology company advancing innovative ...

Educational interventions for patients, including both in-person and online methods, significantly reduced atopic dermatitis (AD) severity.

This article discusses the two conditions, their differences, and how to tell them apart, as well as their symptoms, diagnosis, and treatment options. Atopic dermatitis (AD) is the most common ...

The US Food and Drug Administration (FDA) has approved tapinarof cream, 1% for the treatment of atopic dermatitis (AD) in adults and pediatric patients 2 years of age and older. An aryl ...

Eczema is a group of conditions that make your skin inflamed or irritated. The most common type is atopic dermatitis. Conditions That Can Look Like Eczema but Aren’t Your dermatologist or ...

Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report the Company has completed its Phase 2a clinical trial (NCT06363461) of topical TDM-180935 ...

The results, which are published in JAMA Dermatology, can lead to improved access to treatment for patients ... Cognitive Behavioral Therapy for Atopic Dermatitis, JAMA Dermatology (2024).

The Report also covers current Atopic Dermatitis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying ...

In August 2024, the FDA approved nemolizumab for the treatment of prurigo nodularis in adults. Authorization applications for nemolizumab for atopic dermatitis and prurigo nodularis are under ...